Projects per year
Personal profile
Biography
Professor Leon Bach is a Professor in the Faculty of Medicine at Monash University and Deputy Director of the Department of Endocrinology and Diabetes at the Alfred. His research interests are in the role of glycated proteins in diabetic complications and regulation of the insulin-like growth factor system (including IGF-1) in diseases including cancer and diabetes.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
Network
-
Precision Medicine for hypertension: Early detection of primary aldosteronism
Yang, J., Fuller, P., Young, M., Stowasser, M., Russell, G., Bach, L., Gilfillan, C., Lu, Z. X., Reid, C., Chen, G. & Gwini, S.
1/07/19 → 30/06/23
Project: Research
-
A new model of health-care for co-morbid diabetes and chronic kidney disease
Zoungas, S., Teede, H., Kerr, P., Russell, G., Walker, R., Bach, L., Gallagher, M. P., Fulcher, G. R., Usherwood, T. P., Cass, A., Ranasinha, S., Jan, S., Lo, C. & Zimbudzi, E.
Department of Health and Aged Care (Australia)
22/12/17 → 31/12/18
Project: Research
-
Perioperative Administration of Dexamethasone and Infection- The PADDI trial
Corcoran, T., Bach, L., Chan, M. T. V., Cheng, A., Forbes, A., Ho, K., Leslie, K., Myles, P. & Short, T.
National Health and Medical Research Council (NHMRC) (Australia)
1/11/15 → 31/07/21
Project: Research
-
JDRF/NHMRC Diabetes Complications Centre of Research Excellence
Cooper, M., Thomas, M., El-Osta, S., Jandeleit-Dahm, K., Groop, P., Bach, L., Wilkinson-Berka, J. & Khurana, I.
1/12/14 → 30/11/19
Project: Research
-
Driving with type 1 diabetes: real-world evidence to support starting glucose level and frequency of monitoring during journeys
Trawley, S., Stephens, A. N., McAuley, S. A., Speight, J., Hendrieckx, C., Vogrin, S., Lee, M. H., Paldus, B., Bach, L. A., Burt, M. G., Cohen, N. D., Colman, P. G., Davis, E. A., Holmes-Walker, D. J., Jenkins, A. J., Kaye, J., Keech, A. C., Kumareswaran, K., MacIsaac, R. J., McCallum, R. W., & 6 others , 10 May 2022, In: Diabetes Technology and Therapeutics. 24, 5, p. 350-356 7 p.Research output: Contribution to journal › Article › Research › peer-review
-
Dexamethasone and surgical-site infection
Corcoran, T. B., Myles, P. S., Forbes, A. B., Cheng, A. C., Bach, L. A., O’Loughlin, E., Leslie, K., Chan, M. T. V., Story, D., Short, T. G., Martin, C., Coutts, P., Ho, K. M. & for the PADDI Investigators, the Australian and New Zealand College of Anaesthetists Clinical Trials Network, and the Australasian Society for Infectious Diseases Clinical Research Network, 6 May 2021, In: The New England Journal of Medicine. 384, 18, p. 1731-1741 11 p.Research output: Contribution to journal › Article › Research › peer-review
39 Citations (Scopus) -
Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways
Huang, K. W., Wang, I. H., Fu, P., Krum, H., Bach, L. A. & Wang, B. H., Oct 2021, In: IJC Heart and Vasculature. 36, 6 p., 100852.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Reutens, A. T., Jandeleit-Dahm, K., Thomas, M., Salim, A., De Livera, A. M., Bach, L. A., Colman, P. G., Davis, T. M. E., Ekinci, E. I., Fulcher, G., Hamblin, P. S., Kotowicz, M. A., MacIsaac, R. J., Morbey, C., Simmons, D., Soldatos, G., Wittert, G., Wu, T., Cooper, M. E. & Shaw, J. E., Mar 2020, In: Contemporary Clinical Trials. 90, 8 p., 105892.Research output: Contribution to journal › Article › Other › peer-review
22 Citations (Scopus) -
SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and during Hospital Admission
Hamblin, P. S., Wong, R., Ekinci, E. I., Fourlanos, S., Shah, S., Jones, A. R., Hare, M. J. L., Calder, G. L., Epa, D. S., George, E. M., Giri, R., Kotowicz, M. A., Kyi, M., Lafontaine, N., Macisaac, R. J., Nolan, B. J., O'Neal, D. N., Renouf, D., Varadarajan, S., Wong, J., & 2 others , Aug 2019, In: The Journal of Clinical Endocrinology and Metabolism. 104, 8, p. 3077-3087 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access60 Citations (Scopus)